Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
Authors
Keywords
Continuous infusion, β-lactams, PK/PD, Customized drug dosing, Critical illness, Sepsis
Journal
INFECTION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-01
DOI
10.1007/s15010-019-01352-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial
- (2019) Stefan Hagel et al. Trials
- Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
- (2019) Sofie A.M. Dhaese et al. JOURNAL OF CRITICAL CARE
- Adäquate Antiinfektivatherapie
- (2018) A. Brinkmann et al. ANAESTHESIST
- Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients
- (2018) Nathaniel J. Rhodes et al. CRITICAL CARE MEDICINE
- A UHPLC–MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent
- (2018) Saiyuri Naicker et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
- (2018) Konstantinos Z Vardakas et al. LANCET INFECTIOUS DISEASES
- Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
- (2018) Zhenwei Yu et al. PLoS One
- Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients
- (2017) Claire Roger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
- (2017) Sahand Imani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
- (2016) Abdulaziz S. Alobaid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients
- (2016) Jason A. Roberts et al. BMC INFECTIOUS DISEASES
- Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime
- (2016) Bhagyashri Navalkele et al. CLINICAL INFECTIOUS DISEASES
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review
- (2016) Abdulaziz S. Alobaid et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
- (2015) Joel M. Dulhunty et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
- (2015) Eric A. J. Hoste et al. INTENSIVE CARE MEDICINE
- Anti-Infective Drugs during Continuous Hemodialysis –Using the Bench to Learn What to do at the Bedside
- (2015) Anka C. Roehr et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
- (2015) Mohd H. Abdul-Aziz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
- (2015) Abdulaziz S. Alobaid et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
- (2015) Hui Yang et al. PLoS One
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour
- (2014) Ricard Ferrer et al. CRITICAL CARE MEDICINE
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
- (2013) Gloria Wong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Augmented Renal Clearance in the ICU
- (2013) Andrew A. Udy et al. CRITICAL CARE MEDICINE
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial
- (2013) Jan J. De Waele et al. INTENSIVE CARE MEDICINE
- Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
- (2012) J. M. Dulhunty et al. CLINICAL INFECTIOUS DISEASES
- Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*
- (2012) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects
- (2012) G. Chandorkar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
- (2011) Andrew A. Udy et al. CHEST
- Implications of augmented renal clearance in critically ill patients
- (2011) Andrew A. Udy et al. Nature Reviews Nephrology
- Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation
- (2010) Lois S. Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started